Albany Molecular Research, Inc. Renews Relationship with Eli Lilly and Company
11-Feb-2005
"We believe that Lilly's decision to continue this significant relationship with AMRI reflects the value that AMRI's scientists have been able to bring to the collaboration," said AMRI Chairman, President and Chief Executive Officer Thomas E. D'Ambra, Ph.D.
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.